Werewolf Therapeutics (HOWL) Other financing activities (2020 - 2025)
Werewolf Therapeutics (HOWL) posted quarterly Other financing activities of $48000.0 for Q4 2025, down 27.27% year-over-year from $66000.0 in Q4 2024, and up 17.07% on a QoQ basis from $41000.0 in Q2 2025.
Werewolf Therapeutics (HOWL) Other financing activities (2020 - 2025) Analysis & Trends
Werewolf Therapeutics has reported Other financing activities for 6 years, with the latest figure at $48000.0 in Q4 2025.
- Other financing activities for Q4 2025 came in at $48000.0, down 27.27% year-over-year; the trailing twelve-month figure through Dec 2025 was $89000.0 (down 37.32% YoY), and the FY2025 annual result was $89000.0, down 37.32% from the prior year.
- Other financing activities climbed to $48000.0 in Q4 2025, from $41000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $111.0 million in Q2 2021 and troughed at $1000.0 in Q2 2022.
- A 5-year average of $8.6 million and a median of $48000.0 in 2023 frame the typical range for Other financing activities.
- The widest annual swing landed in 2022, when Other financing activities plunged 100.0%; it then jumped 4400.0% in 2023.
- A 5-year view of Other financing activities shows it stood at $111.0 million in 2021, then plunged by 99.98% to $24000.0 in 2022, then surged by 100.0% to $48000.0 in 2023, then jumped by 37.5% to $66000.0 in 2024, then decreased by 27.27% to $48000.0 in 2025.
- Per Business Quant data, the three most recent Other financing activities figures were $48000.0 in Q4 2025, $41000.0 in Q2 2025, and $66000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Werewolf Therapeutics | 43.94 Mn | 43.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48,000.00 |
| Dec 31, 2025 | 48,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Dec 31, 2024 | -41,000.00 |
| Dec 31, 2024 | -41,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Dec 31, 2022 | 24,000.00 |
| Dec 31, 2022 | 24,000.00 |
| Sep 30, 2022 | 230,000.00 |
| Sep 30, 2022 | 230,000.00 |